Back to Journals » HIV/AIDS - Research and Palliative Care » Volume 12

Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments

Authors Özdener-Poyraz AE, Slugocki M, Kalabalik-Hoganson J, Han J

Received 16 March 2020

Accepted for publication 9 July 2020

Published 28 July 2020 Volume 2020:12 Pages 283—293

DOI https://doi.org/10.2147/HIV.S216024

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Professor Bassel Sawaya


Ayşe Elif Özdener-Poyraz, Malgorzata Slugocki, Julie Kalabalik-Hoganson, Jayoung Han

Fairleigh Dickinson University, School of Pharmacy and Health Sciences, Department of Pharmacy Practice, Florham Park, NJ 07932, USA

Correspondence: Ayşe Elif Özdener-Poyraz
Fairleigh Dickinson University, School of Pharmacy and Health Sciences, Department of Pharmacy Practice, 230 Park Avenue, M-Sp1-01, Florham Park, NJ 07932, USA
Tel +973-443-8211
Email eozdener@fdu.edu

Abstract: Pre-exposure prophylaxis (PrEP) against HIV infection with tenofovir/emtricitabine is proven to be effective yet uptake of this preventive measure has been difficult due to several barriers such as cost, access, and misinformation. Certain subpopulations are disproportionately affected by this problem. Several methods have been developed to close the gap in care. New antiretroviral treatment strategies are being investigated for safety and efficacy in preventing HIV infection.

Keywords: pre-exposure prophylaxis, HIV prevention, PrEP uptake, medications

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]